PMID: 24080162

Conseil G, Cole SP
Two polymorphic variants of ABCC1 selectively alter drug resistance and inhibitor sensitivity of the multidrug and organic anion transporter multidrug resistance protein 1.
Drug Metab Dispos. 2013 Dec;41(12):2187-96. doi: 10.1124/dmd.113.054213. Epub 2013 Sep 30., [PubMed]
Sentences
No. Mutations Sentence Comment
4 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:4:8
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:4:17
status: NEW
view ABCC1 p.Ser92Phe details
Mutants C43S and S92F were correctly routed to the HEK cell plasma membrane, but the levels were too low to permit functional characterization. Login to comment
5 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:5:62
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:5:55
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:5:80
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:5:48
status: NEW
view ABCC1 p.Arg633Gln details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:5:69
status: NEW
view ABCC1 p.Ala989Thr details
In contrast, levels and membrane trafficking of R633Q, G671V, R723Q, A989T, and C1047S were similar to wild-type MRP1. Login to comment
6 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:6:140
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:6:172
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:6:165
status: NEW
view ABCC1 p.Ala989Thr details
In cell-based assays, all five mutants were equally effective at effluxing calcein, but only two exhibited reduced resistance to etoposide (C1047S) and vincristine (A989T; C1047S). Login to comment
7 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:7:268
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:7:193
status: NEW
view ABCC1 p.Ala989Thr details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:7:258
status: NEW
view ABCC1 p.Ala989Thr details
The GSH-dependent inhibitor LY465803 (LY465803 [N-[3-(9-chloro-3-methyl-4-oxo-4H-isoxazolo- [4,3-c]quinolin-5-yl)-cyclohexylmethyl]-benzamide)] was less effective at blocking calcein efflux by A989T, but in a membrane-based assay, organic anion transport by A989T and C1047S was inhibited by MRP1 modulators as well as wild-type MRP1. Login to comment
8 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:8:65
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:8:55
status: NEW
view ABCC1 p.Ala989Thr details
GSH accumulation assays suggest cellular GSH efflux by A989T and C1047S may be impaired. Login to comment
9 ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:9:109
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:9:202
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:9:192
status: NEW
view ABCC1 p.Ala989Thr details
In conclusion, although six in silico analyses consistently predict deleterious consequences of ABCC1 nsSNPs G671V, changes in drug resistance and inhibitor sensitivity were only observed for A989T and C1047S, which may relate to GSH transport differences. Login to comment
27 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:27:170
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:27:109
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Arg433Ser
X
ABCC1 p.Arg433Ser 24080162:27:138
status: NEW
view ABCC1 p.Arg433Ser details
Previously, we generated and partially characterized recombinant forms of ABCC1 nsSNPs: rs45511401 (2012G.T; G671V), rs60782127 (1299G.T; R433S), and rs41395947 (128G.C; C43S) (Conrad et al., 2001, 2002; Leslie et al., 2003). Login to comment
28 ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:28:18
status: NEW
view ABCC1 p.Gly671Val details
We found that the G671V mutation had no deleterious effects on the levels or organic anion (i.e., LTC4, E217bG) transport function of MRP1 when expressed in human embryonic kidney (HEK) cells, despite the fact this mutation is located near NBD1 (Conrad et al., 2001). Login to comment
29 ABCC1 p.Arg433Ser
X
ABCC1 p.Arg433Ser 24080162:29:17
status: NEW
view ABCC1 p.Arg433Ser details
In contrast, the R433S mutant exhibited reduced LTC4 and estrone sulfate transport levels (Conrad et al., 2002). Login to comment
30 ABCC1 p.Arg433Ser
X
ABCC1 p.Arg433Ser 24080162:30:22
status: NEW
view ABCC1 p.Arg433Ser details
ABCC1 p.Arg433Ser
X
ABCC1 p.Arg433Ser 24080162:30:85
status: NEW
view ABCC1 p.Arg433Ser details
Cells expressing MPR1-R433S also showed increased doxorubicin resistance, suggesting R433S can better efflux this drug despite its lower organic anion transport activity. Login to comment
31 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:31:43
status: NEW
view ABCC1 p.Cys43Ser details
Yet another phenotype was observed for the C43S nsSNP in the first TM helix of MSD0. Login to comment
32 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:32:13
status: NEW
view ABCC1 p.Cys43Ser details
Not only did C43S increase organic anion transport activity and reduce resistance to vincristine and arsenite (Leslie et al., 2003), it also mildly disrupted MRP1 membrane trafficking. Login to comment
33 ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:33:135
status: NEW
view ABCC1 p.Ala989Thr details
In a subsequent characterization of the organic anion transport activity of 10 additional ABCC1 nsSNPs, only one (rs35529209; 2965G.A; A989T) showed a significant reduction in E217bG transport (L&#e9;tourneau et al., 2005). Login to comment
34 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:34:179
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:34:132
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Arg433Ser
X
ABCC1 p.Arg433Ser 24080162:34:245
status: NEW
view ABCC1 p.Arg433Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:34:188
status: NEW
view ABCC1 p.Ala989Thr details
In contrast to our experimental data, the predictive algorithms SIFT (Sorting Tolerant From Intolerant) and PolyPhen indicated that G671V would adversely affect MRP1 function but C43S and A989T were less likely to do so, whereas predictions for R433S were mixed (L&#e9;tourneau et al., 2005). Login to comment
40 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:40:6
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:40:18
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:40:25
status: NEW
view ABCC1 p.Ala989Thr details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:40:12
status: NEW
view ABCC1 p.Ser92Phe details
Four (C43S, S92F, G671V, A989T) were mutants that our earlier studies showed had a phenotype discordant from that predicted by Polyphen and/or SIFT (L&#e9;tourneau et al., 2005). Login to comment
41 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:41:19
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:41:12
status: NEW
view ABCC1 p.Arg633Gln details
Two others (R633Q, R723Q) were selected because of their location in NBD1. Login to comment
42 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:42:10
status: NEW
view ABCC1 p.Cys1047Ser details
The last, C1047S, was selected because the predicted probability of this mutation having a deleterious effect by SIFT approached statistical significance. Login to comment
58 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:58:117
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:58:110
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:58:131
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:58:103
status: NEW
view ABCC1 p.Arg633Gln details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:58:124
status: NEW
view ABCC1 p.Ala989Thr details
Lysates (10 mg protein per lane) prepared from HEK293 cell lines expressing wild-type (WT) and mutant (R633Q, G671V, R723Q, A989T, C1047S) MRP1 proteins and the untransfected control cell line (HEK) were immunoblotted, and MRP1 was detected with mAb QCRL-1. Login to comment
96 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:96:58
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:96:48
status: NEW
view ABCC1 p.Ala989Thr details
Total cellular glutathione in HEK293 wild-type, A989T and C1047S cells was measured using the enzymatic recycling method of Tietze (1969) and Brehe and Burch (1976). Login to comment
103 ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:103:48
status: NEW
view ABCC1 p.Ala989Thr details
Tryptic fragmentation patterns of wild-type and A989T mutant MRP1 were determined as described previously elsewhere (Rothnie et al., 2006; Iram and Cole, 2012). Login to comment
104 ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:104:80
status: NEW
view ABCC1 p.Ala989Thr details
Briefly, membrane vesicles (2 mg of protein per lane) enriched for wild-type or A989T mutant MRP1 were incubated in hypotonic buffer (50 mM HEPES, pH 7.4) in the absence or presence of S-methylGSH (10 mM) for 30 minutes on ice. Login to comment
111 ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:111:58
status: NEW
view ABCC1 p.Gly671Val details
All the algorithms and matrices are in agreement that the G671V mutation located close to the Walker A motif in NBD1 is the most likely to affect MRP1 activity. Login to comment
114 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:114:72
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:114:62
status: NEW
view ABCC1 p.Arg633Gln details
The analyses of the two other nsSNPs located in NBD1, namely, R633Q and R723Q, yield results very similar to one another (low probability of adverse effect), except that Arg633 is considered to be more critical to MRP1 stability by I-mutant Suite (Table 1), probably because Arg633 is more strictly conserved than Arg723 (Supplemental Table 1). Login to comment
115 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:115:36
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:115:45
status: NEW
view ABCC1 p.Ser92Phe details
The predicted effects of the nsSNPs C43S and S92F in MSD0 are mixed (Table 1). Login to comment
116 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:116:271
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:116:113
status: NEW
view ABCC1 p.Ser92Phe details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:116:306
status: NEW
view ABCC1 p.Ser92Phe details
They are predicted to be possibly damaging by Polyphen2 but tolerated by SIFT (except for SIFTBLink which places S92F at the threshold), and to cause substantial physicochemical changes and probably low occurrence (Grantham and matrices), yet the I-mutant Suite predicts C43S to be more destabilizing than S92F (Table 1). Login to comment
117 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:117:46
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:117:36
status: NEW
view ABCC1 p.Ala989Thr details
The predicted effects of the nsSNPs A989T and C1047S located in TM12 and TM13 of MSD2, respectively, are also mixed. Login to comment
120 ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:120:114
status: NEW
view ABCC1 p.Gly671Val details
According to this method, the mutants ranked (from highest to lowest likelihood of an adverse effect) as follows: G671V . Login to comment
121 ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:121:0
status: NEW
view ABCC1 p.Ser92Phe details
S92F . Login to comment
122 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:122:0
status: NEW
view ABCC1 p.Cys43Ser details
C43S . Login to comment
123 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:123:0
status: NEW
view ABCC1 p.Cys1047Ser details
C1047S . Login to comment
124 ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:124:0
status: NEW
view ABCC1 p.Arg633Gln details
R633Q . Login to comment
125 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:125:0
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:125:8
status: NEW
view ABCC1 p.Ala989Thr details
R723Q = A989T. Login to comment
126 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:126:21
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:126:14
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:126:39
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:126:7
status: NEW
view ABCC1 p.Arg633Gln details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:126:28
status: NEW
view ABCC1 p.Ala989Thr details
nsSNPs R633Q, G671V, R723Q, A989T, and C1047S Have No Effect on Total on Plasma Membrane MRP1 Levels in HEK293 Cells. Login to comment
127 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:127:114
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:127:107
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:127:132
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:127:100
status: NEW
view ABCC1 p.Arg633Gln details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:127:121
status: NEW
view ABCC1 p.Ala989Thr details
After we had isolated stably transfected HEK293 cell lines by G418 selection, cell lines expressing R633Q, G671V, R723Q, A989T, and C1047S and wild-type MRP1 were cloned to .90% homogeneity for MRP1 expression. Login to comment
128 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:128:160
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:128:153
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:128:113
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:128:99
status: NEW
view ABCC1 p.Arg633Gln details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:128:106
status: NEW
view ABCC1 p.Ala989Thr details
Immunoblots of cell lysates showed that the levels of the five mutant proteins were comparable to (R633Q, A989T, C1047S) or somewhat (,50%) higher than (G671V, R723Q) wild-type MRP1, indicating that the mutations do not cause any major misfolding of MRP1 that would result in its degradation (Fig. 1B). Login to comment
129 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:129:102
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:129:111
status: NEW
view ABCC1 p.Ser92Phe details
However, despite our repeated attempts, HEK cell lines homogeneously expressing the two MSD0 mutants, C43S and S92F, could not be isolated. Login to comment
131 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:131:50
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:131:41
status: NEW
view ABCC1 p.Ser92Phe details
Immunoblots of lysates prepared from the S92F and C43S cell lines showed MRP1 protein levels that were much lower than wild-type MRP1 (Supplemental Fig. 1), as might be expected from nonclonal cell lines. Login to comment
132 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:132:75
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:132:68
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:132:93
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:132:61
status: NEW
view ABCC1 p.Arg633Gln details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:132:82
status: NEW
view ABCC1 p.Ala989Thr details
Confocal fluorescence microscopy experiments showed that the R633Q, G671V, R723Q, A989T, and C1047S mutant proteins in the five clonal HEK cell lines were also routed correctly to the plasma membrane in a manner indistinguishable from wild-type MRP1 (Fig. 2). Login to comment
133 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:133:4
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:133:13
status: NEW
view ABCC1 p.Ser92Phe details
The C43S and S92F mutants in the nonclonal cell populations were also properly routed to the plasma membrane although, as expected because of the heterogeneity of MRP1 expression in these cell lines, significantly fewer cells expressed these proteins (Supplemental Fig. 1). Login to comment
134 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:134:120
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:134:129
status: NEW
view ABCC1 p.Ser92Phe details
Because of the confounding effects of mixed cell populations on the interpretation of subsequent functional assays, the C43S and S92F mutants were not characterized further. Login to comment
136 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:136:44
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:136:37
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:136:62
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:136:30
status: NEW
view ABCC1 p.Arg633Gln details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:136:51
status: NEW
view ABCC1 p.Ala989Thr details
The HEK cell lines expressing R633Q, G671V, R723Q, A989T, and C1047S were tested for their levels of resistance to five xenobiotics for which human MRP1 is known to confer resistance, including the antineoplastic agents vincristine, etoposide (VP-16), doxorubicin, and the heavy metal oxyanions arsenite and antimony tartrate (Cole et al., 1994). Login to comment
138 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:138:213
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:138:203
status: NEW
view ABCC1 p.Ala989Thr details
Levels of vincristine resistance were the most variable, but the differences were only statistically significant (approximately 2.5-fold lower than wild-type MRP1, P , 0.05) in the cell lines expressing A989T and C1047S. Login to comment
139 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:139:28
status: NEW
view ABCC1 p.Cys1047Ser details
Etoposide resistance of the C1047S cell line was also lower than the wild-type MRP1 cell line, but the difference was more modest (1.6-fold; P , 0.05); doxorubicin resistance was also decreased, but the difference was not statistically significant. Login to comment
140 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:140:28
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:140:18
status: NEW
view ABCC1 p.Ala989Thr details
Resistance of the A989T and C1047S cell lines to arsenite was comparable to the wild-type MRP1 cell line while resistance to antimony tartrate was reduced (1.7-fold and 3.0-fold, respectively). Login to comment
141 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:141:346
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:141:619
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:141:545
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:141:728
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:141:485
status: NEW
view ABCC1 p.Arg633Gln details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:141:673
status: NEW
view ABCC1 p.Ala989Thr details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:141:413
status: NEW
view ABCC1 p.Ser92Phe details
TABLE 1 Predicted effects of MRP1 nsSNPs examined in this study according to various in silico prediction methods nsSNP SIFT/SIFTBLink Probability Scoresa PolyPhen2 Classificationb (Score) I-Mutant Suite "Stability"c (DDG in kcal mol21 ) Grantham Value Difference (D)d Blosum50e PAM250f (Threshold) (,0.05) (.1.000) (,20.5; .0.5) (.50) (,0) (,0) C43S 0.51/0.08 possibly damaging (0.819) decrease (20.74) 112 21 0 S92F 0.11/0.05 possibly damaging (0.303) neutral (20.05) 155 23 23 NBD1-R633Q 0.66/0.57 benign (0.001) decrease (21.16) 43 1 1 NBD1-G671V 0.00/0.02 probably damaging (1.000) decrease (20.57) 109 24 21 NBD1-R723Q 0.49/0.39 benign(0.002) decrease (20.71) 43 1 1 A989T 0.53/0.12 benign (0.000) decrease (20.73) 58 0 1 C1047S 0.07/0.64 benign (0.001) decrease (20.67) 112 21 0 a SIFT (Sorting Intolerant From Tolerant) was used by manually entering a sequence alignment comprising only human homologs of MRP1, and SIFT-BLink probability scores were obtained using 100 aligned computer-selected sequences (threshold for nontolerated substitution set at ,0.05). Login to comment
153 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:153:52
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:153:45
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:153:70
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:153:38
status: NEW
view ABCC1 p.Arg633Gln details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:153:59
status: NEW
view ABCC1 p.Ala989Thr details
To determine whether the five nsSNPs, R633Q, G671V, R723Q, A989T, and C1047S, affected the ability of MRP1 to mediate efflux of calcein, HEK293 cells stably expressing wild-type and mutant MRP1 as well as untransfected HEK cells were incubated with several concentrations of the cell permeable acetoxymethyl ester of calcein (calcein-AM) at 37&#b0;C; 3 hours later, the intracellular hydrolyzed calcein that had not been effluxed by MRP1 was measured. Login to comment
157 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:157:101
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:157:91
status: NEW
view ABCC1 p.Ala989Thr details
Thus, unlike the chemosensitivity assay, which showed that the drug-resistance patterns of A989T and C1047S were different from wild-type MRP1 (Table 2), the calcein efflux assay did not detect any differences (Fig. 3). Login to comment
158 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:158:22
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:158:7
status: NEW
view ABCC1 p.Ala989Thr details
nsSNPs A989T, But Not C1047S, Affects the Inhibition of MRP1-Mediated Calcein Efflux by LY465803. Login to comment
159 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:159:61
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:159:51
status: NEW
view ABCC1 p.Ala989Thr details
To further explore the selective effects of nsSNPs A989T and C1047S on their ability to recognize xenobiotics, we determined whether the two mutations affect the efficacy of MRP1 modulators. Login to comment
167 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:167:375
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:167:333
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:167:476
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:167:290
status: NEW
view ABCC1 p.Arg633Gln details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:167:418
status: NEW
view ABCC1 p.Ala989Thr details
TABLE 2 Effect of nsSNP mutations on MRP1-mediated resistance to chemotherapeutic agents and metalloids in HEK293 cell lines Cell Line/ nsSNP Relative Resistancea Vincristine Doxorubicin Etoposide Na+ Arsenite K+ Antimony Tartrate Wild-type 12.2 6 0.6 3.9 6 1.6 7.1 6 0.6 1.4; 2.2 5.2; 6.4 R633Q 15.3 6 2.9 3.3 6 1.0 5.1 6 0.9 ND ND G671V 9.3 6 2.8 3.4 6 0.6 7.1 6 0.7 ND ND R723Q 21.3 6 7.2 2.5 6 0.1 6.9 6 0.5 ND ND A989T 4.4 6 1.1b ** 2.5 6 0.6 5.0 6 0.9 1.6; 2.3 3.1; 3.5 C1047S 5.1 6 0.5*** 1.8 6 0.2 4.5 6 0.7* 2.0; 1.8 2.2; 1.7 ND, not determined. Login to comment
172 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:172:46
status: NEW
view ABCC1 p.Cys1047Ser details
Similarly, the calcein efflux activity of the C1047S mutant was completely inhibited. Login to comment
173 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:173:558
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:173:53
status: NEW
view ABCC1 p.Ala989Thr details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:173:399
status: NEW
view ABCC1 p.Ala989Thr details
However, the fluorescence levels in cells expressing A989T were decreased by 50%, indicating that the mutation had diminished the ability of LY465803 to inhibit MRP1. Similarly, in the converse experiment, when cells were preincubated with increasing concentrations of LY465803 before adding a single concentration of calcein-AM (6 mM), the fluorescence levels observed for the cells expressing the A989T mutant were consistently ;50% lower than the fluorescence levels in the control untransfected HEK293 cells as well as the cells expressing wild-type and C1047S mutant MRP1 at all LY465803 concentrations tested (Fig. 4B). Login to comment
174 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:174:17
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:174:7
status: NEW
view ABCC1 p.Ala989Thr details
nsSNPs A989T and C1047S Do Not Affect Inhibition of [3 H]E217bG Vesicular Transport by LY465803 and the Leukotriene Modifiers LY171883 and BAYu9773. Login to comment
175 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:175:316
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:175:31
status: NEW
view ABCC1 p.Ala989Thr details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:175:270
status: NEW
view ABCC1 p.Ala989Thr details
To determine whether the nsSNP A989T also affected the sensitivity of MRP1 to the GSH-dependent LY465803 inhibitor in a vesicular transport assay, the ability of LY465803 to inhibit uptake of [3 H]E217bG into membrane vesicles prepared from the HEK cell line expressing A989T was examined; cell lines expressing the C1047S mutant and wild-type MRP1 were included as controls. Login to comment
176 ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:176:66
status: NEW
view ABCC1 p.Ala989Thr details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:176:121
status: NEW
view ABCC1 p.Ala989Thr details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:176:224
status: NEW
view ABCC1 p.Ala989Thr details
Preliminary experiments confirmed that E217bG vesicular uptake by A989T was partially (50%) reduced in vesicles from the A989T HEK cell line, as it had been shown previously in vesicles prepared from transiently transfected A989T HEK cells (L&#e9;tourneau et al., 2005) (Supplemental Fig. 2). Login to comment
178 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:178:132
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:178:303
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:178:105
status: NEW
view ABCC1 p.Ala989Thr details
As can be seen in Table 3 from the data summary of multiple experiments, the IC50 values of LY465803 for A989T (0.05 6 0.01 mM) and C1047S (0.03 6 0.03 mM) were not significantly different from the IC50 for wild-type MRP1 (0.07 6 0.01 mM) although the difference approached statistical significance for C1047S (P = 0.07). Login to comment
180 ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:180:155
status: NEW
view ABCC1 p.Ala989Thr details
BAYu9773, a nonselective antagonist of the CysLT receptors 1 and 2 and LY171883, a selective antagonist of CysLT receptor 1, inhibited E217bG transport by A989T with IC50 values of 0.32 6 0.19 mM and 19.58 6 6.15 mM, respectively. Login to comment
181 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:181:174
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:181:319
status: NEW
view ABCC1 p.Cys1047Ser details
These values were not significantly different from the IC50 values obtained for BAYu9773-mediated and LY171883-mediated inhibition of E217bG transport by either wild-type or C1047S MRP1 (Table 3) (0.69 6 0.18 mM and 0.62 6 0.16 mM [for BAYu9773] and 16.10 6 1.28 mM and 23.90 6 9.85 mM [for LY171883] for wild-type and C1047S, respectively; P . Login to comment
183 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:183:27
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:183:17
status: NEW
view ABCC1 p.Ala989Thr details
Effect of nsSNPs A989T and C1047S on [3 H]GSH Transport and Cellular GSH Levels. Login to comment
184 ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:184:12
status: NEW
view ABCC1 p.Ala989Thr details
Because the A989T nsSNP was associated with a decreased inhibitory potency of the GSH-dependent LY465803 inhibitor in a cell-based (where its effects are dependent on intracellular GSH concentrations) but not in a membrane-based transport assay (where exogenous GSH is provided and is not limiting), it was of interest to determine whether vesicular transport of GSH and/or cellular levels of GSH were affected by this nsSNP. Login to comment
185 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:185:4
status: NEW
view ABCC1 p.Cys1047Ser details
The C1047S mutant was included for comparative purposes. Login to comment
186 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:186:75
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:186:65
status: NEW
view ABCC1 p.Ala989Thr details
As shown in Fig. 6A, levels of apigenin-stimulated GSH uptake by A989T and C1047S were 16% and 26% lower than for wild-type MRP1, but in neither case were these differences statistically significant (P = 0.2 and 0.16, respectively). Login to comment
187 ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:187:69
status: NEW
view ABCC1 p.Ala989Thr details
Thus, the difference in results obtained with LY465803 and the nsSNP A989T in the cell-based versus membrane-based Fig. 3. Login to comment
189 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:189:77
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:189:70
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:189:91
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:189:63
status: NEW
view ABCC1 p.Arg633Gln details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:189:84
status: NEW
view ABCC1 p.Ala989Thr details
HEK293 cells stably expressing wild-type (WT-MRP1) and mutant (R633Q, G671V, R723Q, A989T, C1047S) MRP1 were incubated in the presence of increasing concentrations of calcein-AM (0-6mM), and the intracellular calcein remaining in the cells after 3 hours was measured by fluorometry as described in Materials and Methods. Login to comment
191 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:191:113
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:191:103
status: NEW
view ABCC1 p.Ala989Thr details
Effect of the MRP1 inhibitor LY465803 on calcein accumulation in HEK293 cells expressing wild-type and A989T and C1047S mutant MRP1 proteins. Login to comment
198 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:198:85
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:198:342
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:198:75
status: NEW
view ABCC1 p.Ala989Thr details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:198:332
status: NEW
view ABCC1 p.Ala989Thr details
In contrast to the wild-type MRP1 cell line, the GSH levels present in the A989T and C1047S cell lines were comparable (106% and 94%, respectively) to those of the control untransfected cell line, suggesting that both nsSNPs adversely affect the ability of MRP1 to efflux GSH from intact cells (P = 0.08 and 0.02, respectively, for A989T and C1047S cells compared with wild-type MRP1 cells). Login to comment
199 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:199:17
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:199:7
status: NEW
view ABCC1 p.Ala989Thr details
nsSNPs A989T and C1047S Have No Major Impact on the Protease Susceptibility of MRP1. Login to comment
200 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:200:54
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:200:44
status: NEW
view ABCC1 p.Ala989Thr details
Because the functional changes detected for A989T and C1047S were the most significant among all the nsSNPs tested, we determined whether any of these changes were associated with any differences in protein conformation as reflected by a change in protease susceptibility. Login to comment
203 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:203:218
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:203:207
status: NEW
view ABCC1 p.Ala989Thr details
As shown in Supplemental Fig. 3A, when blots were probed with mAbs MRPr1 and 42.4 that detect epitopes in the NH2-half of MRP1, no differences in the tryptic fragment patterns obtained were observed between A989T (and C1047S, data not shown) and wild-type MRP1. Similarly, no differences were detected when the blots were probed with mAbs MRPm5, 897.2, and MRPm6, which detect epitopes located in the COOH-half of MRP1 (Supplemental Fig. 3B). Login to comment
210 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:210:102
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:210:92
status: NEW
view ABCC1 p.Ala989Thr details
Effect of MRP1 modulators on ATP-dependent vesicular uptake of [3 H]E217bG by wild-type and A989T and C1047S mutant MRP1. Login to comment
211 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:211:91
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:211:76
status: NEW
view ABCC1 p.Ala989Thr details
Membrane vesicles prepared from HEK293 cells expressing wild-type [WT (d)], A989T (s), and C1047S (m) mutant MRP1 were preincubated with a range of concentrations of (A) BAYu9773, (B) LY171883, and (C) LY465308 (+ GSH), and then ATP-dependent [3 H]E217bG uptake was measured after 5 minutes in the continued presence of the modulators as described in Materials and Methods. Login to comment
214 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:214:91
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:214:81
status: NEW
view ABCC1 p.Ala989Thr details
TABLE 3 Effect of MRP1 modulators on ATP-dependent vesicular uptake of E217bG by A989T and C1047S mutant MRP1 The values shown represents the mean IC50 values 6 S.D. obtained from three independent experiments performed using two different preparations of membrane vesicles. Login to comment
215 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:215:26
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:215:20
status: NEW
view ABCC1 p.Ala989Thr details
IC50 (mM) Wild-Type A989T C1047S LY465803 (+ GSH) 0.07 6 0.01 0.05 6 0.01 0.03 6 0.03 BAYu9773 0.62 6 0.16 0.32 6 0.19 0.69 6 0.18 LY171883 16.10 6 1.28 19.58 6 6.15 23.90 6 9.85 and compared the experimental data obtained with stable HEK cell lines with the consequences of the amino acid substitutions predicted by various in silico methods. Login to comment
217 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:217:51
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:217:66
status: NEW
view ABCC1 p.Ser92Phe details
The first category includes the two nsSNPs in TM1 (C43S) and TM2 (S92F) that could not be functionally characterized because stable homogeneously expressing clonal HEK cell lines for these mutants could not be isolated. Login to comment
220 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:220:132
status: NEW
view ABCC1 p.Cys43Ser details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:220:141
status: NEW
view ABCC1 p.Ser92Phe details
However, most in silico prediction programs based on chemical properties, amino acid conservation, and structural data classify the C43S and S92F nsSNPs as very likely to be deleterious to MRP1 function. Login to comment
221 ABCC1 p.Cys43Ser
X
ABCC1 p.Cys43Ser 24080162:221:27
status: NEW
view ABCC1 p.Cys43Ser details
Previously, we showed that C43S expressed in HeLa cells was associated with decreased arsenite and vincristine resistance, and moderately impaired MRP1 trafficking to the plasma membrane (Leslie et al., 2003). Login to comment
225 ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:225:21
status: NEW
view ABCC1 p.Ser92Phe details
ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:225:137
status: NEW
view ABCC1 p.Ser92Phe details
The inability of the S92F mutant to be established as a stable homogenously expressing HEK cell line is also somewhat unexpected because S92F was readily expressed in transiently transfected HEK cells (L&#e9;tourneau et al., 2005). Login to comment
226 ABCC1 p.Ser92Phe
X
ABCC1 p.Ser92Phe 24080162:226:23
status: NEW
view ABCC1 p.Ser92Phe details
In this latter system, S92F transported organic anions LTC4, E217bG, and methotrexate at levels only modestly below those of wild-type MRP1. Login to comment
227 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:227:97
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:227:90
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:227:83
status: NEW
view ABCC1 p.Arg633Gln details
The second category of mutants examined includes the three nsSNPs located in NBD1 (R633Q, G671V, R723Q), which exhibited little, if any, change in transport levels or sensitivity to MRP1 substrates or inhibitors. Login to comment
228 ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:228:4
status: NEW
view ABCC1 p.Arg633Gln details
For R633Q, this is not surprising because Arg633 is not located in or close to any functionally important motifs in NBD1. Login to comment
230 ABCC1 p.Arg633Gln
X
ABCC1 p.Arg633Gln 24080162:230:54
status: NEW
view ABCC1 p.Arg633Gln details
Thus, our results here showing little or no effect of R633Q on MRP1 expression or function are consistent with in silico predictions and with our earlier study on transiently transfected cells (L&#e9;tourneau et al., 2005). Login to comment
231 ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:231:20
status: NEW
view ABCC1 p.Gly671Val details
This contrasts with G671V, which all prediction algorithms, physicochemical parameters, and structure analyses concur should be deleterious (Table 2). Login to comment
232 ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:232:12
status: NEW
view ABCC1 p.Gly671Val details
Indeed, the G671V mutation ranked as the most damaging of all seven nsSNPs examined here. Login to comment
235 ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:235:3
status: NEW
view ABCC1 p.Gly671Val details
T (G671V) nsSNP has been associated with an altered response to certain drugs, including adverse reactions, in several studies. Login to comment
240 ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:240:113
status: NEW
view ABCC1 p.Gly671Val details
These findings are consistent with our earlier observation that lymphocytes from normal individuals bearing this G671V nsSNP expressed ABCC1 mRNA at relatively low levels (Conrad et al., 2001), and they suggest a change in mRNA structure is more important than the amino acid change caused by this nSNP. Login to comment
244 ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:244:87
status: NEW
view ABCC1 p.Gly671Val details
ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:244:163
status: NEW
view ABCC1 p.Gly671Val details
The reasons for the discordance between most of the experimental observations with the G671V mutant protein versus the uniformly adverse effects predicted for the Val substitution of Gly671 by the in silico analytical methods and the genetic association studies are unclear but may well be related to the cellular context in which the Fig. 6. Login to comment
245 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:245:65
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:245:55
status: NEW
view ABCC1 p.Ala989Thr details
Apigenin-stimulated vesicular transport of [3 H]GSH by A989T and C1047S mutant MRP1 and intracellular glutathione content. Login to comment
246 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:246:183
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:246:173
status: NEW
view ABCC1 p.Ala989Thr details
(A) ATP-dependent uptake of [3 H]GSH (100 mM/120 nCi) in the presence of apigenin (30 mM) was measured in membrane vesicles prepared from HEK293 cells expressing wild-type, A989T and C1047S MRP1 for 20 minutes at 37&#b0;C. Login to comment
250 ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:250:106
status: NEW
view ABCC1 p.Gly671Val details
It is also possible that analyses in a cell culture setting may not be adequate to discern all aspects of G671V function. Login to comment
251 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:251:20
status: NEW
view ABCC1 p.Arg723Gln details
With respect to the R723Q nsSNP, a conserved positive charge is lost (Supplemental Table 1), and the side chain has been shortened. Login to comment
253 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:253:48
status: NEW
view ABCC1 p.Arg723Gln details
Consequently, in this case, the prediction that R723Q would be a benign substitution by five out of six in silico methods used is consistent with the experimental data reported here in a stable HEK cell line as well as in our earlier study in transiently transfected HEK cells (L&#e9;tourneau et al., 2005). Login to comment
254 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:254:104
status: NEW
view ABCC1 p.Arg723Gln details
ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:254:231
status: NEW
view ABCC1 p.Arg723Gln details
However, in contrast with our observations, Yin et al. (2009) reported that HEK cells stably expressing R723Q exhibited varying degrees of reduced resistance to natural product drugs and that the plasma membrane trafficking of the R723Q protein was mildly impaired. Login to comment
256 ABCC1 p.Arg723Gln
X
ABCC1 p.Arg723Gln 24080162:256:124
status: NEW
view ABCC1 p.Arg723Gln details
It is of interest that in a small phase III study of Caucasian patients with advanced multiple myeloma, the presence of the R723Q nsSNP in 5 of 279 patients being treated with bortezomib and pegylated liposomal doxorubicin was associated with a different overall response rate and durability (Buda et al., 2010). Login to comment
258 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:258:51
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:258:41
status: NEW
view ABCC1 p.Ala989Thr details
The third and final category consists of A989T and C1047S which, despite the fact that most predictive methods indicated they were unlikely to affect MRP1 activity, exhibited altered phenotypes that distinguished them not only from wild-type MRP1 but to some degree from each other. Login to comment
259 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:259:36
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:259:27
status: NEW
view ABCC1 p.Ala989Thr details
Thus, HEK cells expressing A989T or C1047S differed in their drug-resistance profiles and their sensitivity to LY465803- mediated inhibition of calcein efflux, as well as their cellular GSH levels as detected in cell-based assays. Login to comment
260 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:260:4
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:260:72
status: NEW
view ABCC1 p.Ala989Thr details
The C1047S affected both vincristine and etoposide resistance while the A989T mutation affected only vincristine resistance. Login to comment
262 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:262:99
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:262:79
status: NEW
view ABCC1 p.Ala989Thr details
Inhibition of calcein efflux by the GSH-dependent LY465803 was also reduced in A989T cells but not C1047S cells. Login to comment
263 ABCC1 p.Cys1047Ser
X
ABCC1 p.Cys1047Ser 24080162:263:80
status: NEW
view ABCC1 p.Cys1047Ser details
ABCC1 p.Ala989Thr
X
ABCC1 p.Ala989Thr 24080162:263:70
status: NEW
view ABCC1 p.Ala989Thr details
In contrast, membrane-based vesicular transport assays indicated that A989T and C1047S did not affect the ability of LY465803 to inhibit MRP1-mediated E217bG uptake. Login to comment
269 ABCC1 p.Gly671Val
X
ABCC1 p.Gly671Val 24080162:269:133
status: NEW
view ABCC1 p.Gly671Val details
Typically, either a cell-based or membrane-based functional assay is used to measure MRP1 function, but experience with the 2012C.T (G671V) allele suggests that additional nucleic acid-based methods should also be included. Login to comment